395-27118-16141
3 vaccinations
2 coded responses
30 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
-
2020-12-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-29
-
2021-01-05
Dose 2 — Pfizer-BioNTech
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-20
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-04-08
- 2021-07-08
-
2021-08-25
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-29
- 2021-10-06
-
2021-11-24
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose, sore throat in November 2021 3 months after the third shot- 3 negative covid testsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Myalgia, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: Covid 29 with fevers, myalgias, congestion, cough , fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-08-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-08-25 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Runny nose, sore throat in November 2021 3 months after the third shot- 3 negative covid tests
Release 11 — 6 months, dose 3
Symptoms: Covid 29 with fevers, myalgias, congestion, cough , fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release